Cargando…
Metformin regulates lipid metabolism in a canine model of atrial fibrillation through AMPK/PPAR-α/VLCAD pathway
BACKGROUND: Atrial lipid metabolic remodeling is critical for the process of atrial fibrillation (AF). Abnormal Fatty acid (FA) metabolism in cardiomyocytes is involved in the pathogenesis of AF. MET (Metformin), an AMPK (AMP-activated protein kinase) activator, has been found to be associated with...
Autores principales: | Bai, Fan, Liu, Yaozhong, Tu, Tao, Li, Biao, Xiao, Yichao, Ma, Yingxu, Qin, Fen, Xie, Jing, Zhou, Shenghua, Liu, Qiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511207/ https://www.ncbi.nlm.nih.gov/pubmed/31077199 http://dx.doi.org/10.1186/s12944-019-1059-7 |
Ejemplares similares
-
Metformin improves lipid metabolism and reverses the Warburg effect in a canine model of chronic atrial fibrillation
por: Liu, Yaozhong, et al.
Publicado: (2020) -
Metformin regulates adiponectin signalling in epicardial adipose tissue and reduces atrial fibrillation vulnerability
por: Li, Biao, et al.
Publicado: (2020) -
Quantitative acetylated proteomics on left atrial appendage tissues revealed atrial energy metabolism and contraction status in patients with valvular heart disease with atrial fibrillation
por: Tu, Tao, et al.
Publicado: (2022) -
Mendelian Randomization Integrating GWAS, eQTL, and mQTL Data Identified Genes Pleiotropically Associated With Atrial Fibrillation
por: Liu, Yaozhong, et al.
Publicado: (2021) -
Comparison between High-Power Short-Duration and Conventional Ablation Strategy in Atrial Fibrillation: An Updated Meta-Analysis
por: Li, Mohan, et al.
Publicado: (2022)